RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, welcomes Mikey Santiago as its new Chief Information Officer. In this role, Mikey will lead Avantor's global information technology strategy, advancing the company's digital transformation agenda while supporting growth, operational [...]

Tokyo, Japan – Rigaku Corporation, a global solutions partner in X-ray analytical instruments and a group company of Rigaku Holdings Corporation (Headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), together with Kyoto University, Shimadzu Corporation, JEOL Ltd., Hitachi, Ltd., Hitachi High-Tech Corporation, and HORIBA, Ltd., has established the Kyoto University Advanced Technology Development Alliance [...]

London – Cenevo, a specialist in enabling connected agentic labs for life sciences, today announced the launch of the Mosaic Ordering Assistant, a new AI assistant that turns plain-language requests into orders for sample preparation. Trusted by 8 of the top 10 pharmaceutical companies, Mosaic is the platform life sciences labs rely on for sample ordering. [...]

Bringing next-generation binder design models into production discovery Basel, Switzerland — Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the addition of the new RFD4-Proteina binder design model into Genedata's AI-enabled discovery workflows, following the model's introduction at NVIDIA GTC Berlin. As an early ecosystem partner, Genedata is [...]

New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude purification through final polishing WILMINGTON, Del. – DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide therapeutics, including [...]

Agreement gives KU Leuven’s Leuven Viral Vector Core access to foundational CRISPR/Cas9 intellectual property, supporting genome editing services for academic and industry researchers worldwide Dublin, Ireland, and Leuven, Belgium: ERS Genomics Limited (‘ERS Genomics’), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with KU Leuven covering CRISPR/Cas9 activities at [...]

The Trusted Research Environment will support secure data management, regional collaboration and advanced genomic analysis MOUNTAIN VIEW, Calif. -- CariGenetics has established the Caribbean's first Trusted Research Environment (TRE) to strengthen the secure management and analysis of genomic and associated health data generated through its research across the Caribbean. The goal of this collaboration is [...]

DRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts are now available in early access, incorporating new AI-driven approaches to analysis, automation, and discovery The tools automate end-to-end informatics processes at scale and help customers build private data lakes to drive scientific and clinical research insights SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) [...]

The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies Builds on existing partnerships at BioLabs sites across the US, Germany and France Hamburg, Germany and MUNICH, Germany – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around [...]

QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an offer price of €46.50 per share, a premium of 40.3% to the unaffected share price Following a comprehensive review of strategic options, QIAGEN’s Supervisory Board and Managing Board fully support the transaction and agreed to unanimously [...]